Search
Patexia Research
Case number 3:24-cv-08162

ASTRAZENECA PHARMACEUTICALS LP et al v. NATCO PHARMA LIMITED et al > Summary

Court Case Number 3:24-cv-08162

Filing Date Jul 31, 2024

Court New Jersey District Court

Status Unknown

JudgesRobert Kirsch

Plaintiff

3

AstraZeneca

Corporation For International Business, Inc.

KuDOS Pharmaceuticals Limited

Defendant

Natco Pharma Ltd.

Related Patents

Doc No Title Issue date
12048695 Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one Jul 30, 2024
11975001 Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one May 7, 2024
11970530 Methods of treating homologous recombination deficient cancer Apr 30, 2024
11633396 Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H- phthalazin-1-one Apr 25, 2023
08859562 Use of RNAI inhibiting PARP activity for the manufacture of a medicament for the treatment of cancer Oct 14, 2014
08475842 Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one Jul 2, 2013
07449464 Phthalazinone derivatives Nov 11, 2008
Menu